Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ...

Which company has contributed the most to this earnings growth? The answer is Merck. The company has experienced a massive inversion in its adjusted earnings per share (EPS). In Q2 2023, the ...

Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29RAHWAY, N.J.-- (BUSINESS WIRE)-- Merck (NYSE: MRK), known as MSD outside of the United States and Canada, will hold its ...

Merck Foundation, the philanthropic arm of Merck KGaA Germany, conducted the 7 th Edition of Merck Foundation First Ladies Initiative - MFFLI Summit 2025 in Dubai, United Arab Emirates.

Merck’s potential for upside hinges on its ability to execute on several key fronts: successfully advancing its pipeline, expanding geographically, and making strategic acquisitions.

Jim Parkinson, the designer behind Rolling Stone's iconic logo, has died at 83 after a long battle with Alzheimer’s, his friend confirmed.

In this analysis, we explore the potential upside for Merck despite its short-term hurdles.

An outside group of experts agreed that the CDC should recommend a new antibody drug that offers protection against RSV for infants and babies.

RFK Jr.’s vaccine panel endorsed Merck’s RSV shot for babies, easing fears that his stance might delay rollout.

The CDC’s ACIP has blessed Merck’s new RSV shot Enflonsia, but the decision was not resounding from Robert F. Kennedy Jr.’s new panel of experts.

A new slate of vaccine advisers to the US Centers for Disease Control and Prevention voted Thursday to recommend that Americans receive influenza vaccines that are free of thimerosal even though ...

On June 26 RFK Jr.'s newly appointed seven-member vaccine advisory panel voted 5-2 to recommend Merck's RSV antibody shot clesrovimab.